Mark Simons

Remy Biosciences believes there is a better way to deliver active ingredients into the body, and by doing so achieving better wellness for all. We've spent years proving what can be done, and building the mechanisms with which to do so. Remy focuses on foundational intellectual property for delivery of molecules and compounds transdermally, through the dermal (skin) layer, as well as orally, through sublingual tablets that deliver molecules through mucosal pathways (under the tongue). The portfolio summarized below is inclusive of formally issued and pending patents worldwide.